General description
Meglumine antimoniate is a antimony derivative used to treat visceral, cutaneous and mucosal leishmaniasis.
ATC codes
Medicine type
Chemical agent
EML status history
First added in 1987
(TRS
770)
for
Visceral leishmaniasis
Added in 1987
(TRS
770)
for
Mucocutaneous leishmaniasis
Added in 1987
(TRS
770)
for
Cutaneous leishmaniasis
Wikipedia
Recommendations
Section
Antileishmaniasis medicines
- Parenteral > General injections > IM: 1.5 g per 5 mL in 5 mL ampoule